Progressive pulmonary fibrosis: an expert group consensus statement.
Rajan SK, Cottin V, Dhar R, Danoff S, Flaherty KR, Brown KK, Mohan A, Renzoni E, Mohan M, Udwadia Z, Shenoy P, Currow D, Devraj A, Jankharia B, Kulshrestha R, Jones S, Ravaglia C, Quadrelli S, Iyer R, Dhooria S, Kolb M, Wells AU.
Eur Respir J. 2023 Mar 30;61(3):2103187. doi: 10.1183/13993003.03187-2021. Print 2023 Mar.
Update on cryptogenic organizing pneumonia.
Radzikowska E, Fijolek J.
Front Med (Lausanne). 2023 Apr 20;10:1146782. doi: 10.3389/fmed.2023.1146782. eCollection 2023.
Pulmonary Complications of Systemic Lupus Erythematosus.
Hannah JR, D'Cruz DP.
Semin Respir Crit Care Med. 2019 Apr;40(2):227-234. doi: 10.1055/s-0039-1685537. Epub 2019 May 28.
The Evolving Profile of Idiosyncratic Drug-Induced Liver Injury.
Fontana RJ, Bjornsson ES, Reddy R, Andrade RJ.
Clin Gastroenterol Hepatol. 2023 Jul;21(8):2088-2099. doi: 10.1016/j.cgh.2022.12.040. Epub 2023 Mar 1.
Drug induced pulmonary parenchymal disease.
Prasad R, Gupta P, Singh A, Goel N.
Drug Discov Ther. 2014 Dec;8(6):232-7. doi: 10.5582/ddt.2014.01046.
Drug-induced lung disease: a narrative review.
Bridi GDP, Fonseca EKUN, Kairalla RA, Amaral AF, Baldi BG.
J Bras Pneumol. 2024 Sep 27;50(4):e20240110. doi: 10.36416/1806-3756/e20240110. eCollection 2024.
Eosinophilic Pneumonias.
Allen J, Wert M.
J Allergy Clin Immunol Pract. 2018 Sep-Oct;6(5):1455-1461. doi: 10.1016/j.jaip.2018.03.011. Epub 2018 May 4.
Roflumilast.
[No authors listed]
2018 Jun 4. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.
Drug-induced adverse pulmonary reactions.
White JP, Ward MJ.
Adverse Drug React Acute Poisoning Rev. 1985 Winter;4(4):183-211.
Drug-induced pulmonary vascular disease--mechanisms and clinical patterns.
Kumar K, Holden WE.
West J Med. 1986 Sep;145(3):343-9.
